TABLE 1.
Clinical data summary
| Value | |
|---|---|
| Total no. of patients | 47 |
| Total no. of metastases | 51 |
| Total no. of specimens | 91 |
| Age, yrs, median (range) | 61 (36–82) |
| Sex | |
| Female | 34 (72%) |
| Male | 13 (28%) |
| ICG dose, mg/kg | |
| 5 | 26 (55%) |
| 2.5 | 21 (45%) |
| Time from ICG infusion to visualization, hrs, mean (range) | 23.3 (15.9–29.2) |
| Prior op | 6 (13%) |
| Prior radiation | 18 (38%) |
| No. of metastases per patient | |
| Single | 39 (83%) |
| Multiple | 8 (17%) |
| Tumor size, largest diameter, in mm | |
| Mean | 28.1 |
| Median (range) | 24 (13–69) |
| Tumor laterality | |
| Lt | 21 (45%) |
| Rt | 22 (47%) |
| Bilat | 4 (9%) |
| Tumor location | |
| Frontal | 18 (35%) |
| Parietal | 11 (22%) |
| Temporal | 7 (14%) |
| Occipital | 11 (22%) |
| Cerebellar | 4 (8%) |
| Primary pathology | |
| Lung cancer | 20 (43%) |
| Breast cancer | 9 (19%) |
| Melanoma | 6 (13%) |
| Colon cancer | 3 (6%) |
| Others (ovarian, renal, prostate, endocervical, esophageal) | 9 (19%) |
| Postop radiation therapy | |
| SRS | 39 (83%) |
| WBRT | 2 (4%) |
| No radiation | 6 (13%) |
Values are presented as number (%) of patients unless otherwise Indicated.